Gerber Hans-Peter相关文献与解析，生知库

The Anti-FRÎ± Antibody-Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non-Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death.

抗 FRα 抗体药物偶联物 Luveltamab Tazevibulin 在非小细胞肺癌临床前模型中显示出疗效，并诱导免疫原性细胞死亡

Yuan Robert, McGeehan Andrew, Zhou Sihong, Cheng Christine, Armanini Mark, Smith Jennifer, Embry Millicent, Pena Rhoneil, Lewis Danielle K, Hernandez Genevive, Bajjuri Krishna, Tran Cuong, Yin Gang, Abrahams Cristina, Li Xiaofan, Gerber Hans-Peter, Yam Alice, Kiefel Helena

细胞生物学

肺癌

发表日期：2025

文献求助收藏

TCR mimic compounds for pHLA targeting with high potency modalities in oncology

用于肿瘤治疗的高效靶向pHLA的TCR模拟化合物

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2022.1027548

Gerber, Hans-Peter; Presta, Leonard G

Antibody drug-conjugates targeting the tumor vasculature: Current and future developments

靶向肿瘤血管的抗体药物偶联物：现状与未来发展

期刊:MAbs

影响因子:7.3

doi:10.4161/mabs.1.3.8515

Gerber, Hans-Peter; Senter, Peter D; Grewal, Iqbal S

The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts

VEGF-A在晶状体发育中的作用：形成玻璃体毛细血管网和预防暂时性核性白内障

期刊:Experimental Eye Research

影响因子:2.7

doi:10.1016/j.exer.2008.07.017

Garcia, Claudia M; Shui, Ying-Bo; Kamath, Meera; DeVillar, Justin; Johnson, Randall S; Gerber, Hans-Peter; Ferrara, Napoleone; Robinson, Michael L; Beebe, David C

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma

抗CD30-奥瑞他汀-E抗体药物偶联物（SGN-35）与化疗联合应用可提高霍奇金淋巴瘤的抗肿瘤活性。

期刊:British Journal of Haematology

影响因子:3.8

doi:10.1111/j.1365-2141.2008.07146.x

Oflazoglu, Ezogelin; Kissler, Kim M; Sievers, Eric L; Grewal, Iqbal S; Gerber, Hans-Peter

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

表达人源化VEGF-A的小鼠可能有助于深入了解抗VEGF抗体的安全性和有效性。

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.0611492104

Gerber, Hans-Peter; Wu, Xiumin; Yu, Lanlan; Wiesmann, Christian; Liang, Xiao Huan; Lee, Chingwei V; Fuh, Germaine; Olsson, Christine; Damico, Lisa; Xie, David; Meng, Y Gloria; Gutierrez, Johnny; Corpuz, Racquel; Li, Bing; Hall, Linda; Rangell, Linda; Ferrando, Ron; Lowman, Henry; Peale, Franklin; Ferrara, Napoleone

HIF-1alpha is essential for myeloid cell-mediated inflammation

HIF-1α对髓系细胞介导的炎症至关重要

期刊:Cell

影响因子:42.5

doi:10.1016/s0092-8674(03)00154-5

Cramer, Thorsten; Yamanishi, Yuji; Clausen, Björn E; Förster, Irmgard; Pawlinski, Rafal; Mackman, Nigel; Haase, Volker H; Jaenisch, Rudolf; Corr, Maripat; Nizet, Victor; Firestein, Gary S; Gerber, Hans Peter; Ferrara, Napoleone; Johnson, Randall S

Multi-modal feature learning to prioritize ADCs with favorable half-life in mice

利用多模态特征学习方法筛选在小鼠体内半衰期较好的抗体药物偶联物（ADC）。

Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations

具有双重有效载荷的均质抗体-药物偶联物：潜力、方法和注意事项

The Anti-FRÎ± Antibody-Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non-Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death.

抗 FRα 抗体药物偶联物 Luveltamab Tazevibulin 在非小细胞肺癌临床前模型中显示出疗效，并诱导免疫原性细胞死亡

TCR mimic compounds for pHLA targeting with high potency modalities in oncology

用于肿瘤治疗的高效靶向pHLA的TCR模拟化合物

Antibody drug-conjugates targeting the tumor vasculature: Current and future developments

靶向肿瘤血管的抗体药物偶联物：现状与未来发展

The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts

VEGF-A在晶状体发育中的作用：形成玻璃体毛细血管网和预防暂时性核性白内障

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma

抗CD30-奥瑞他汀-E抗体药物偶联物（SGN-35）与化疗联合应用可提高霍奇金淋巴瘤的抗肿瘤活性。

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

表达人源化VEGF-A的小鼠可能有助于深入了解抗VEGF抗体的安全性和有效性。

HIF-1alpha is essential for myeloid cell-mediated inflammation

HIF-1α对髓系细胞介导的炎症至关重要